{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:35:11Z","timestamp":1790660111201,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.arcped.2026.105545","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:47:15Z","timestamp":1782420435000},"page":"105545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and tolerance of GLP-1 analogues in the treatment of adolescent obesity: analysis of a French population"],"prefix":"10.1016","volume":"33","author":[{"given":"Sarah","family":"Bouhmouch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0065-5344","authenticated-orcid":false,"given":"B\u00e9atrice","family":"Dubern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Terraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2138-6702","authenticated-orcid":false,"given":"Patrick","family":"Tounian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2026.105545_bib0001","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1210\/er.2017-00111","article-title":"Obesity pathogenesis: an endocrine society scientific statement","volume":"38","author":"Schwartz","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcped.2026.105545_bib0002","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-13-0414","article-title":"Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS","volume":"221","author":"Van Bloemendaal","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1016\/j.arcped.2026.105545_bib0003","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.febslet.2007.11.063","article-title":"Neuronal control of energy homeostasis","volume":"582","author":"Gao","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.arcped.2026.105545_bib0004","doi-asserted-by":"crossref","first-page":"R1048","DOI":"10.1152\/ajpregu.90701.2008","article-title":"A tasty morsel: the role of the dorsal vagal complex in the regulation of food intake and swallowing. Focus on \u201cBDNF\/TrkB signaling interacts with GABAergic system to inhibit rhythmic swallowing in the rat,\u201d by Bariohay et al","volume":"295","author":"Bailey","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.arcped.2026.105545_bib0005","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1172\/JCI200113914","article-title":"Selective deletion of leptin receptor in neurons leads to obesity","volume":"108","author":"Cohen","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcped.2026.105545_bib0006","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrendo.2016.222","article-title":"The cellular and molecular bases of leptin and ghrelin resistance in obesity","volume":"13","author":"Cui","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arcped.2026.105545_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101351","article-title":"GLP-1 physiology informs the pharmacotherapy of obesity","volume":"57","author":"Drucker","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.arcped.2026.105545_bib0008","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.diabres.2012.02.016","article-title":"Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes","volume":"97","author":"Horowitz","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.arcped.2026.105545_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101635","article-title":"Interventions to prevent obesity in school-aged children 6-18 years: an update of a Cochrane systematic review and meta-analysis including studies from 2015 to 2021","volume":"54","author":"Hodder","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.arcped.2026.105545_bib0010","article-title":"Interventions to prevent obesity in children aged 12 to 18 years old","volume":"5","author":"Spiga","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2026.105545_bib0011","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.physbeh.2007.11.025","article-title":"Association of cognitive restraint with ghrelin, leptin, and insulin levels in subjects who are not weight-reduced","volume":"93","author":"Schur","year":"2008","journal-title":"Physiol Behav"},{"key":"10.1016\/j.arcped.2026.105545_bib0012","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Chirurgie de l\u2019ob\u00e9sit\u00e9 pour les moins de 18 ans : \u00e0 n\u2019envisager que dans des cas tr\u00e8s particuliers. [Internet] Saint-Denis La Plaine (FR) : HAS; Accessed September 7, 2024 . Available from: https:\/\/www.has-sante.fr\/jcms\/c_2621051\/fr\/chirurgie-de-l-obesite-pour-les-moins-de-18-ans-a-n-envisager-que-dans-des-cas-tres-particuliers."},{"key":"10.1016\/j.arcped.2026.105545_bib0013","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.arcped.2023.06.006","article-title":"Bariatric procedures including Roux-en-Y gastric bypass in French adolescents","volume":"30","author":"Lacrosniere","year":"2023","journal-title":"Arch P\u00e9diatrie"},{"key":"10.1016\/j.arcped.2026.105545_bib0014","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1080\/14656566.2020.1748599","article-title":"The limits and challenges of antiobesity pharmacotherapy","volume":"21","author":"Gadde","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.arcped.2026.105545_bib0015","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-068119","article-title":"GLP-1 receptor agonists in pediatric and adolescent obesity","volume":"155","author":"Stefater-Richards","year":"2025","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2026.105545_bib0016","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamapediatrics.2025.3243","article-title":"Efficacy and safety of GLP-1 RAs in children and adolescents with obesity or type 2 diabetes : a systematic review and meta- analysis","volume":"179","author":"Kotecha","year":"2025","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.arcped.2026.105545_bib0017","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2147\/JMDH.S419245","article-title":"Usage of glucagon-like peptide-1 for obesity in children; updated review of Clinicaltrials.Gov","volume":"16","author":"Alorfi","year":"2023","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.arcped.2026.105545_bib0018","first-page":"13","article-title":"Body mass index variations: centiles from birth to 87 years","volume":"45","author":"Rolland-Cachera","year":"1991","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.arcped.2026.105545_bib0019","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12624","article-title":"A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity","volume":"15","author":"Weghuber","year":"2020","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.arcped.2026.105545_bib0020","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity","volume":"387","author":"Weghuber","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2026.105545_bib0021","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","article-title":"A randomized, controlled trial of liraglutide for adolescents with obesity","volume":"382","author":"Kelly","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2026.105545_bib0022","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/oby.22369","article-title":"Heterogeneity in response to treatment of adolescents with severe obesity: the need for precision obesity medicine","volume":"27","author":"Ryder","year":"2019","journal-title":"Obesity"},{"key":"10.1016\/j.arcped.2026.105545_bib0023","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/oby.2011.337","article-title":"Exenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot study","volume":"20","author":"Kelly","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/j.arcped.2026.105545_bib0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2026.105545_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.13061","article-title":"Evaluating potential predictors of weight loss response to liraglutide in adolescents with obesity: a post hoc analysis of the randomized, placebo-controlled SCALE Teens trial","volume":"18","author":"Bensignor","year":"2023","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.arcped.2026.105545_bib0026","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000368963","article-title":"Predicting weight loss and maintenance in overweight\/obese pediatric patients","volume":"82","author":"Wiegand","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.arcped.2026.105545_bib0027","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.arcped.2026.105545_bib0028","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/MOP.0000000000001379","article-title":"Use of glucagon-like-peptide 1 receptor agonist in the treatment of childhood obesity","volume":"36","author":"Kavarian","year":"2024","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.arcped.2026.105545_bib0029","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/00185787221125724","article-title":"Tirzepatide","volume":"58","author":"Baker","year":"2023","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.arcped.2026.105545_bib0030","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple\u2013Hormone-receptor agonist retatrutide for obesity\u2014a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X26000916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X26000916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:26:13Z","timestamp":1783578373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X26000916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0929693X26000916"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2026.105545","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and tolerance of GLP-1 analogues in the treatment of adolescent obesity: analysis of a French population","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2026.105545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 fran\u00e7aise de p\u00e9diatrie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105545"}}